Introduction
It is not completely clear how the authors are separating GIP from UIP, since some of the illustrated cases show features of GIP and UIP but case 10, for example, is classified as UIP. ?? Radiology.. HRCT It would be helpful if a description of the distribution of changes were included so as to allow correlation with the actual biopsy site(s) in each case. EPMA The methods previously described by the authors are understood, and the lack of true individual particle analysis is recognized, but the description of the 'qualitative element analysis' vs the mapping is not clearly described. Are there results for the qualitative analyses? If the authors meant the areas mapped varied from 5x5 um to 10x10 um this is not correct. From the one figure which is labled, the area mapped is approximately 1.55 mm x 1.55 mm. The other maps have no scale on them, so it is not possible to know what the dimensions are. A minor typo in the 2nd to last sentence says 'legion' when the authors probably meant 'lesion'.
RESULTS

Subject characterization
It is not clear why the patch testing was done only in those with allergic history? Would it not have been of interest to determine if there were sensitization to cobalt in the others? Could a lymphocyte proliferation test be done as in Beryllium disease? It is also of interest that most of the cases are never-smokers, as has been seen in Beryllium disease and hypersensitivity pneumonitis (HP). This has also been seen in hard metal disease series of cases. Page 10, in the last sentence before Table 3 , it needs clarification /explanation of what the authors mean by the statement that 'although centrilobular micronidular opacities were noted in these patients, they were unremarkable' [emphasis added]. Table 3 . Radiologic findings This table could be a logical and useful place to put in the comparison of zonal differences with biopsy site(s) information.
Pathological findings and elemental analysis In the 2nd paragraph, it refers to Figure 4 , which is only presenting results from case 10, but there is no EPMA mapping shown for the areas of case 10 which showed centrilobular pattern or the cannibalistic giant cells in Figure 3 . Could this be included and discussed perhaps? Table 4 There is one case (#16) with both VATS and autopsy. What was the time interval between biopsy and autopsy? and what if any differences were seen in the histopathology? There are some cases in the literature (including one of Liebow's original cases) which had more that one lung tissue sampling showing different histopathologic findings over time. This could be discussed as well. This is a nice retrospective analysis of the pathology of a relatively large number of subjects (considering the rarity of the condition) with hard-metal lung disease (GIP or UIP with W in their lungs). As indicated above, the main shortcoming of the analysis (acknowledged by the authors) is the absence of longitudinal data to answer the main question of the article, i.e. does GIP evolve to UIP? The authors suggest that the answer to this relevant question is NO, but does this then also imply that subjects who worked in the hardmetal industry and develop UIP/fibrosis with W and Ta in the biopsies do not have hard-metal lung disease? In their discussion page 16-17, it is not clear what they conclude.
Specific and Minor comments -It is unclear to what extent the patients described here overlap with those described in the authors' previous publication, even though it is stated that 8 patients were common to this study and those of ref 7 (please specify in table 1).
-It would be interesting to have the authors' background data on element analysis (for W, Ta, ...) in other cases of UIP.
-page 4, line 13: replace "and " by "or"; line 18: replace "is" by "are"; line 37: delete "the" before UIP; line 45: thought by whom? (please provide reference, if any).
-page 5, patient population: please provide more details about period of inclusion, number of pathologists included, etc -page 6, line 6: replace "underwent" by "had undergone" -page 6, line 35: "each tissue sample": did you obtain paraffinembedded tissue from various pathologists? -page 7, lines 10-13: the representativeness of the element analysis for the whole tissue should be addressed -page 7, line 47: how long was the delay between cessation of exposure and biopsy in the 5 patients who were no longer exposed? -page 8, line 11: "no bizarre multinucleated giant cells in BAL": did you analyze the cytology slides or was this feature not reported in the patient notes (my experience is that cytologists may overlook this) -page 10, description of HRCT : this could be elaborated on slightly more, and I suggest a final radiological "diagnosis" could be mentioned in RESPONSE: Page 9, line 8 to 10. At first we thought that 8 cases were already reported in our previous paper, but found 6 of 19 cases; case 2, 5, 7, 8, 10, and 16 corresponding to case 1, 3, 5, 6, 14, and 16 in 2007 report respectively, were in it. When we enrolled the 6 patients in this paper, we noticed some errors in the previous paper, which were that case 10 (14 in 2007) was non-smoker and Ta was detected in case 16 (also 16 in 2007). We added corrected information of those 6 cases in Results.
COMMENT: How were the analyses previously reported different from any of the analyses done in the same cases reported in this study?
RESPONSE: Element analyses were not different from the previous report, but we included clinical data and CT findings of the 6 cases reported in the present study.
COMMENT: Some authors on previous publications were not included in this study which includes some of the same cases?
RESPONSE:
They left the institutes they belonged to in the previous study and did not participate in the Tokyo ILD Meeting. Last time we focused on pathology and immnohistochemistry of lung tissue of the disease, while in this study we evaluated clinical features and CT findings which were not analyzed before.
That is a reason why we excluded them from the present study. Pathological diagnosis of UIP is sometimes controversial because each pathologist has his/her own diagnostic criteria of UIP consisting of heterogeneous appearance honeycomb change and fibroblast foci. We attach greater importance to patchy appearance at low magnification than to any other components. Since centrilobular involvement and giant cell are apparent, we changed the diagnosis of case 10 as predominant UIP with GIP. Actually the same case was pathologically diagnosed as atypical GIP in the previous report. Diagnosis of UIP with GIP should be much appropriate to describe the actual pathological findings of the case. We changed the diagnosis of case 10 to UIP with GIP.
COMMENT: It would be helpful if a description of the distribution of changes were included so as to allow correlation with the actual biopsy site(s) in each case.
Page 13, table 3 and page 15, table 4. We had not evaluated the distribution of changes, but added radiological diagnosis in Table 3 in connection with biopsy site(s) in Table 4 to help readers correlate the pathology with the radiologic findings.
COMMENT: ..but the description of the 'qualitative element analysis' vs the mapping is not clearly described.
Page 8, line 6 to 11. In fact, our technique can simultaneously reveal presence of elements and draw maps. Each pixel in the focused areas of 5 x 5 to 10 x 10 μm in the tissue was scanned by three wavelength dispersive crystals; RAP, PET, and LiF for screening elements of Al, K, RAP; Si, K, PET; Ti, K, LiF; Cr, K, LiF; Fe, K, LiF; Co, K, LiF; Ta, M, PET; W, M, PET, and Zn, L, RAP. Since generated X-ray signals from each pixel were the smallest part of a distribution map, we can obtain element maps by scanning all pixels in the focused area. We revised the methods section.
COMMENT:
Are there results for the qualitative analyses?
RESPONSE: Yes, we have results of qualitative analysis by the screening describe above, but did not show them in the study because they may give little information about the issue discussed in the article.
If the authors meant the areas mapped varied from 5x5 μm to 10x10 μm this is not correct. From the one figure which is labeled, the area mapped is approximately 1.55 mm x 1.55 mm.
RESPONSE:
Page 8, line 3 to 7. We at first screen wider areas raging about 1.5 mm x 1.5 mm at largest when we decide interested areas for fine mapping. Then we focused in three areas of 5 x 5 μm to 10 x 10 μm at smallest in the centrilobular legion of GIP which cover most of the affected areas in a specimen to obtain fine images of EPMA analysis. We revised the sentences to describe exact procedures of element mapping.
COMMENT:
A minor typo in the 2nd to last sentence says 'legion' when the authors probably meant 'lesion'.
RESPONSE: Page 8, line 4.
We corrected the typo.
COMMENT: Subject characterization
It is not clear why the patch testing was done only in those with allergic history? Would it not have been of interest to determine if there were sensitization to cobalt in the others? Could a lymphocyte proliferation test be done as in Beryllium disease?
RESPONSE:
We understand the reviewer's comment and the patch testing would be useful and informative to realize disease etiology, but it requires specialists in dermatology and not much popular in Japan. A lymphocyte proliferation test is available to help make diagnoses of drug-induced diseases, but is not performed to any other diseases in Japan.
COMMENT: COMMENT: Page 10, in the last sentence before Table 3 , it needs clarification /explanation of what the authors mean by the statement that 'although centrilobular micronodular opacities were noted in these patients, they were unremarkable' [emphasis added].
Page 12, line 6 to 8. We mean that centrilobular micronodular opacities were recognized on HRCT, but they were minor findings. We corrected the sentence.
COMMENT: We had not evaluated zonal distribution of changes in chest CT, but added information of biopsy sites and radiological diagnosis of every patient in Table 3 Biopsy specimen contained apical cap-like subpleural dense fibrosis which was composed of airspace fibrosis (intraluminar organization) with collapse and increased elastic framework. The pleura showed fibrous thickening. In autopsy, we noticed remarkable subpleural elastosis with a few of cannibalistic giant cells. We added the information in the results.
COMMENT:
Were other potential causes of pulmonary fibrosis searched for, such as asbestos or silica? and if polarized light examination for birefringent particles such as silica were done).?
RESPONSE:
When we pathologically examine lung tissue, we make notes if asbestos bodies were observed, but did not find in any cases. We did not search other materials by polarized light examination.
COMMENT: Perhaps this could be clarified, in the light of knowledge of similarities between HMD, chronic Be disease (CBD) and HP?
RESPONSE: Page 17, line 1 to 5 from the bottom. According to the reviewer's suggestion, we revised the sentences.
COMMENT: page 15. paragraph starting with "UIP pattern is the pathological abnormality essential to the diagnosis of IPF." It is not specific for IPF, however, since if a cause is identified it is no longer idiopathic PF, of course.
Page 18, line 12 to 13. As the reviewer indicated, the sentence is not correct in this context. We revised the sentence. When we make a diagnosis of the patient, we at first noticed patchy appearance at low magnification.
Higher magnification then revealed other findings of honeycombing and fibroblastic foci with centrilobular lesions and giant cells. That is a reason why we rather made a pathological diagnosis of UIP for the patient. We changed the diagnosis of case 10 as UIP with GIP.
COMMENT:
The conclusion (or really, speculation) that 'inhaled hard metal elements in UIP pattern may not trigger as much inflammation as in GIP' is not supported or refuted by the observations made at a time of biopsy or autopsy.
Individual immune susceptibility/response may be the more important factor, no?
RESPONSE: Page 18, line 1 from the bottom to page 19, line 2. We agree with the reviewer's comment and revised the sentence.
COMMENT:
The sentence 'However, the pathological findings of UIP pattern demonstrated no microscopic connection between centrilobular fibrosis and the UIP area, .." is not fully supported, unless were excluded by specifically searching for them, as noted above re asbestos, silica, etc..
RESPONSE:
Page 19, line 4 from the bottom to page 20, line 1. We mean here that centrilobular fibrosis does not have physical connection to subpleural fibrosing area in microscopic view. Since centrilobular fibrosis is usually irreversible, if GIP induced by W evolved to UIP, sequel of centrilobular fibrosis would be somewhat linked to peripheral UIP lesions. We revised the sentence so as not to lead to misunderstanding.
COMMENT:
The scales for the magnification are present only in one of the EPMA figures.
RESPONSE: Figure 4 and its legend on page 29. Scale bars for the magnification were inserted to representatives of the EPMA images.
Reviewer Name B. NEMERY Institution and Country KU Leuven, Belgium RESPONSE Page 6, line 6 to 8, page 8, line 1 from the bottom to page 9, line1 to 6, and page 10, Table 1 . It was not a nationwide survey, but announcement of the meeting with request for submission of suspected cases. Because the announcement was distributed to the major medical institutes and hospitals which treat interstitial lung diseases and usually rare lung diseases such as hard metal lung diseases would be consulted to the physician's affiliated hospitals in Japan, we believe that the surveillance was fairly comprehensive. When we held the Tokyo ILD Meeting, 22 cases were collected and suspected to be hard metal lung diseases due to occupational history and pathological findings, but 3 cases were excluded because W/Co were not detected in the lung tissue. In 4 of 19 patients, the presence of W, Co or Ta was not known in the first place and proved by the element analysis for the first time at the meeting. More than 5 pulmonary pathologists participated in the meeting, but actually 2 of them, YK and AH involved in decision of the final diagnosis as observers. Exposure period and biopsy/autopsy time of the patients were indicated in revised Table 1 . We revised sentences in the methods and results section added occupational data in Table 1 .
COMMENT
The authors suggest that the answer to this relevant question is NO, but does this then also imply that subjects who worked in the hard-metal industry and develop UIP/fibrosis with W and Ta in the biopsies do not have hard-metal lung disease? RESPONSE Page 20, line 13 to 19. We conclude that GIP does not evolve to UIP because of differences in distribution of fibrosis, hard metal elements, and clinical features. If we find W or Co in the biopsies of UIP/fibrosis from the subjects who worked in the hard-metal industry, we cannot help making a diagnosis of hard-metal lung disease. Given present information, we have to say that the UIP/fibrosis may be induced by W/Co or Ta, or just a coincidence. As the reviewer comments only longitudinal data should allow us to answer the question if GIP evolves to UIP or not.
COMMENT Specific and Minor comments -It is unclear to what extent the patients described here overlap with those described in the authors' previous publication. RESPONSE Page 9, line 8 to 10. At first we thought that 8 cases were already reported in our previous paper, but found 6 of 19 cases; case 2, 5, 7, 8, 10, and 16 corresponding to case 1, 3, 5, 6, 14, and 16 in 2007 report respectively, were as such. When we introduce the 6 patients in this paper, we noticed some errors in the previous paper, which were that case 10 (14 in 2007) was non-smoker and Ta was detected in case 16 (also
